Showing results (1-10 of 247) with videos related to
Sort By:
Pageof 25
Journal of Parkinson'S Disease|March 12, 2017
Replacing Dopamine Neurons in Parkinson's Disease: How did it happen?Anders Björklund, Olle LindvallNeurorx : the Journal of the American Society for Experimental Neurotherapeutics|February 18, 2005
Cell therapy in Parkinson's diseaseOlle Lindvall, Anders BjörklundNeurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|September 9, 2011
Cell therapeutics in Parkinson's diseaseOlle Lindvall, Anders BjörklundThe European Journal of Neuroscience|May 1, 1989
Hippocampal Noradrenaline and Serotonin Release over 24 Hours as Measured by the Dialysis Technique in Freely Moving Rats: Correlation to Behavioural Activity State, Effect of Handling and Tail-PinchPeter Kalén, Evald Rosegren, Olle Lindvall, et al.The European Journal of Neuroscience|January 1, 1991
Host Brain Regulation of Fetal Locus Coeruleus Neurons Grafted to the Hippocampus in 6-Hydroxydopamine-Treated Rats. An Intracerebral Microdialysis StudyPeter Kalén, M. Angela Cenci, Olle Lindvall, et al.The European Journal of Neuroscience|June 2, 2005
Functional properties and synaptic integration of genetically labelled dopaminergic neurons in intrastriatal graftsAndreas Toft Sørensen, Lachlan Thompson, Deniz Kirik, et al.Movement Disorders : Official Journal of the Movement Disorder Society|March 4, 2010
Characterization of Lewy body pathology in 12- and 16-year-old intrastriatal mesencephalic grafts surviving in a patient with Parkinson's diseaseJia-Yi Li, Elisabet Englund, Håkan Widner, et al.Cell Stem Cell|June 19, 2012
Why is it taking so long to develop clinically competitive stem cell therapies for CNS disorders?Olle LindvallPhilosophical Transactions of the Royal Society of London. Series B, Biological Sciences|September 30, 2015
Treatment of Parkinson's disease using cell transplantationOlle LindvallMovement Disorders : Official Journal of the Movement Disorder Society|February 13, 2013
Developing dopaminergic cell therapy for Parkinson's disease--give up or move forward?Olle LindvallPageof 25